Weekly Digest – 06-12 May 2023 Weekly Digest – 06-12 May 2023 May 09, 2023: Seclidemstat (Oral) / Ewing sarcoma / Salarius Pharmaceuticals: The clinical hold on the Phase 1/2 trial has been lifted by the FDA FDA removed the […]
Weekly Digest – 06-12 May 2023 Weekly Digest – 06-12 May 2023 May 09, 2023: Trivehexin (RAD 301) / Pancreatic Cancer / Radiopharm Theranostics: Received Orphan Drug Designation for PDAC Trivehexin (RAD 301) radiopharmaceuticals being developed for imaging and treatment […]
Weekly Digest – 06-12 May 2023 Weekly Digest – 06-12 May 2023 May 09, 2023: Sintilimab (IV) / Bevacizumab (IV) / NSCLC / Innovent Bio: Received China NMPA approval for EGFR-mutated Non-squamous NSCLC who progressed after EGFR-TKI therapy The approval […]
Weekly Digest – 06-12 May 2023 Weekly Digest – 06-12 May 2023 May 07, 2023: Toripelimab (IV) / ES – SCLC / Junshi Bio: Phase 3 EXTENTORCH study met its primary endpoint Phase 3 EXTENTORCH study evaluating Toripelimab plus Chemo […]
Weekly Digest – 06-12 May 2023 Weekly Digest – 06-12 May 2023 May 06, 2023: Brukinsa (Zanubrutinib) / Chronic lymphocytic leukemia (CLL) /Small lymphocytic lymphoma (SLL) / Waldenstrom’s macroglobulinemia (WM) / BeiGene: Received NMPA approval for multiple indications This approval […]
